SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GZMO
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Extra Pale who wrote (391)10/8/2001 2:53:33 PM
From: Extra Pale  Read Replies (2) of 438
 
From my notes of 2nd quarter conference call (7/19)

"Collaborations:
Certain amount of arrogance here - on track for two collaborations by year-end:
1) Antigen discovery - unlike purdue pharm deal, will likely seek codevelopment rights
2) Antibody/anti-angiogenesis collaboration, will seek significant codevelopment and commercialization rights"

Self-abusing musings: should I buy more because of expectations of major collaborations within the next 3 months or should I bail because management is not delivering? This question is complicated by management's indirect guidance that upfront cash from collaborations could offset need for equity offering that will likely be required soon (same c.c. notes say gzmo has cash sufficient to fund operations until 3rd quarter 02)

anyone have ideas as to how to resolve this situation?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News